Advertisement
Loading...

Immix Biopharma, Inc.

IMMX•NASDAQ
Healthcare
Biotechnology
$8.78
$0.11(1.27%)
U.S. Market opens in NaNh NaNm

Immix Biopharma, Inc. (IMMX) Stock Overview

Explore Immix Biopharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap477.7M
P/E Ratio-9.66
EPS (TTM)$-0.92
ROE-0.73%
Fundamental Analysis

AI Price Forecasts

1 Month$9.32
3 Months$13.12
1 Year Target$6.99

IMMX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Immix Biopharma, Inc. (IMMX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.71, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $6.99.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -9.66 and a market capitalization of 477.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.27%
5-Day Change
-12.46%
1-Month Change
-13.75%
3-Month Change
9.75%
6-Month Change
102.77%
Year-to-Date (YTD) Change
67.88%
1-Year Change
264.32%
3-Year Change
401.71%
5-Year Change
139.24%
All-Time (Max) Change
139.24%

Contact Information

https://www.immixbio.com
310 651 8041
11400 West Olympic Boulevard, Los Angeles, CA, 90064

Company Facts

18 Employees
IPO DateDec 16, 2021
CountryUS
Actively Trading

Frequently Asked Questions